Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Blue Sail Medical Co.,Ltd. (002382.SZ)
CNY5.96
+0.54 (+9.96%)
CN SHZ Healthcare Medical - Instruments & Supplies
Address
48 Yinuo Road 255400
Zibo, CN
Zibo, CN
CEO
Shuqiao Zhong
Website
bluesail.cn
IPO
2010-04-02
ISIN CNE100000MZ7
Description
Blue Sail Medical Co.,Ltd. is a global enterprise based in Zibo, China, specializing in the production and distribution of a wide array of protective gloves. Its offerings include disposable medical, latex, nitrile, PVC, TPE, and household gloves, which are utilized across various sectors such as medical examination and protection, food processing, and the electronics industry. Beyond its glove business, the company actively engages in the research, development, manufacturing, and sales of cardiac stents and associated equipment for interventional cardiac surgery. Established in 2002, the company was formerly named Shandong Blue Sail Plastic & Rubber Co., Ltd. before adopting its current identity, Blue Sail Medical Co.,Ltd., in July 2014.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY5.96
+0.54 (+9.96%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
30M
Beta
0.08
Float Shares
697.56M
Free Float %
69.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.29% | -3.76% | -12.21% | +5.26% | +11.69% | +14.29% | +18.74% | -18.68% | -70.53% | -40.02% | -34.03% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
5.96
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
0.88
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%-8.2% Q1'26: +9.9% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%-72.7% Q1'26: -98.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%-10.5% Q1'26: -3.6% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%-6.8% Q1'26: +8.3% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%-4.8% Q1'26: +4.0% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%-1.4% ★ Q1'26: +3.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×6.88× ★ Q1'26: 1.81× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.51B
est: 1.50B (+0.7%)
|
1.29B
est: 1.58B (-18.2%)
|
1.58B
est: 1.58B (0.0%)
|
2.65B
est: 2.65B (+0.0%)
|
3.48B
est: 3.48B (0.0%)
|
7.87B
est: 8.29B (-5.1%)
|
8.96B
est.
|
8.11B
est: 33.75B (-76.0%)
|
4.90B
est: 5.08B (-3.5%)
|
4.93B
est: 5.08B (-2.9%)
|
6.25B
est: 5.92B (+5.7%)
|
5.74B
est: 6.06B (-5.3%)
|
7.75B
7.75B – 7.75B
+27.9% YoY
|
8.41B
8.41B – 8.41B
+8.6% YoY
|
| EBITDA |
276.63M
est: 205.50M (+34.6%)
|
267.27M
est: 215.92M (+23.8%)
|
309.26M
est: 216.05M (+43.1%)
|
571.89M
est: 363.70M (+57.2%)
|
879.75M
est: 476.53M (+84.6%)
|
2.43B
est: 1.14B (+113.4%)
|
1.23B
est.
|
1.80B
est: 4.63B (-61.0%)
|
200.61M
est: 695.87M (-71.2%)
|
69.06M
est: 695.87M (-90.1%)
|
392.00M
est: 440.06M (-10.9%)
|
183.45M
est: 450.70M (-59.3%)
|
576.41M
576.41M – 576.41M
+27.9% YoY
|
625.80M
625.80M – 625.80M
+8.6% YoY
|
| EBIT |
231.35M
est: 89.89M (+157.4%)
|
222.03M
est: 94.45M (+135.1%)
|
257.29M
est: 94.51M (+172.2%)
|
436.85M
est: 159.10M (+174.6%)
|
693.99M
est: 208.45M (+232.9%)
|
2.21B
est: 497.32M (+344.9%)
|
537.44M
est.
|
1.49B
est: 2.02B (-26.6%)
|
-272.46M
est: 304.40M (-189.5%)
|
-438.21M
est: 304.40M (-244.0%)
|
-118.87M
est: -56.99M (-108.6%)
|
-389.07M
est: -58.37M (-566.6%)
|
-74.65M
-74.65M – -74.65M
-27.9% YoY
|
-81.04M
-81.04M – -81.04M
-8.6% YoY
|
| Net Income |
170.21M
est: 369.65M (-54.0%)
|
181.07M
est: 465.86M (-61.1%)
|
200.86M
est: 415.23M (-51.6%)
|
346.71M
est: 410.16M (-15.5%)
|
490.30M
est: 516.50M (-5.1%)
|
1.76B
est: 3.26B (-46.1%)
|
4.63B
est.
|
1.16B
est: 2.53B (-54.4%)
|
-372.32M
est: -425.35M (+12.5%)
|
-568.36M
est: -425.35M (-33.6%)
|
-445.61M
est: -79.89M (-457.8%)
|
-758.94M
est: -748.95M (-1.3%)
|
479.33M
479.33M – 479.33M
+164.0% YoY
|
549.23M
549.23M – 549.23M
+14.6% YoY
|
| SGA |
146.17M
est: 125.99M (+16.0%)
|
141.72M
est: 132.38M (+7.1%)
|
135.72M
est: 132.46M (+2.5%)
|
513.66M
est: 222.98M (+130.4%)
|
761.98M
est: 292.15M (+160.8%)
|
681.17M
est: 697.02M (-2.3%)
|
753.24M
est.
|
765.15M
est: 2.84B (-73.0%)
|
701.86M
est: 426.63M (+64.5%)
|
788.43M
est: 426.63M (+84.8%)
|
814.49M
est: 692.14M (+17.7%)
|
327.80M
est: 708.87M (-53.8%)
|
906.59M
906.59M – 906.59M
+27.9% YoY
|
984.27M
984.27M – 984.27M
+8.6% YoY
|
| EPS |
0.35
est: 0.37 (-4.1%)
|
0.37
est: 0.46 (-19.6%)
|
0.41
est: 0.41 (+0.0%)
|
0.47
est: 0.41 (+16.0%)
|
0.51
est: 0.51 (+0.0%)
|
1.82
est: 3.22 (-43.5%)
|
4.57
est.
|
1.13
est: 2.50 (-54.8%)
|
-0.37
est: -0.42 (+11.9%)
|
-0.56
est: -0.42 (-33.3%)
|
-0.44
est: -0.08 (-450.0%)
|
-0.76
est: -0.75 (-1.3%)
|
0.48
0.48 – 0.48
+164.0% YoY
|
0.55
0.55 – 0.55
+14.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-29.73M
OE per share TTM
-0.01
Owner's Yield
-0.47%
Maintenance CapEx ratio
2,088.25%
Maint CapEx / Avg PPE
75.6%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 20 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.02% | 138.2K | 0.65% |
| 2 | State Street SPDR S&P Emerging Asia Pacific ETF GMF | 0.00% | 17.1K | 0.49% |
| 3 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 231.5K | 0.06% |
| 4 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 28.6K | 0.46% |
| 5 | State Street SPDR Portfolio Emerging Markets ETF SPEM | 0.00% | 209.1K | 0.07% |
| 6 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 90.6K | 0.39% |
| 7 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 58.0K | 0.29% |
| 8 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 13.1K | 0.26% |
| 9 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 5.8K | 0.48% |
| 10 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 645.7K | 0.06% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-48.1K
Shares Outstanding
1.01B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jie Huang | Vice President, Chief Legal Officer & Board Secretary | — | female |
| Mucun Zhang | Vice President | — | male |
| Shuqiao Zhong | President, GM, Chief Capital Officer & Non-Independent Director | — | male |
| Yongchen Zhang | Vice President | — | male |
| Yuntao Cui | Vice President, Accounting Supervisor & Chief Financial Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002382.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
